Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04497727 · ClinicalTrials.gov registry record
Gut Organoid and Microbiome Interactions in Hypertension
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 35
- Enrollment target
NCT04497727 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 35 participants.
The verdict
NCT04497727 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The study compared basic properties of gut epithelia of hypertensive and normotensive reference subjects. The study determined if there are fundamental differences in the gut epithelium in hypertension compared to normotension. Specifically, this study examined gene expression profiles of gut organoids derived from biopsy samples of hypertensive and normotensive individuals undergoing clinically indicated colonoscopy.
Interventions
- OTHER Gene Expression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2024-04-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04497727
The ClinicalTrials.gov registry entry for NCT04497727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gene Expression is the first listed.
NCT04497727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04497727 about?
NCT04497727 is a clinical study titled "Gut Organoid and Microbiome Interactions in Hypertension". The study compared basic properties of gut epithelia of hypertensive and normotensive reference subjects. The study determined if there are fundamental differences in the gut epithelium in hypertension compared to normotension. Specifically, this study examined gene expression profiles of gut organo...
What is the current status of trial NCT04497727?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2021-03-05. Estimated completion is 2024-04-21.
What interventions are being tested in trial NCT04497727?
The interventions under investigation include: Gene Expression (OTHER).
Who is sponsoring clinical trial NCT04497727?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.